Presentation is loading. Please wait.

Presentation is loading. Please wait.

November 5, 2014 Matthew Tuck, MD Hospitalist, Veterans Affairs Medical Center Assistant Professor of Medicine, George Washington University.

Similar presentations


Presentation on theme: "November 5, 2014 Matthew Tuck, MD Hospitalist, Veterans Affairs Medical Center Assistant Professor of Medicine, George Washington University."— Presentation transcript:

1 November 5, 2014 Matthew Tuck, MD Hospitalist, Veterans Affairs Medical Center Assistant Professor of Medicine, George Washington University

2 http://www.npr.org/2014/04/18/304140932/born-with-hiv- building-a-future

3  Take a minute to think about…  What this story made you feel?  What this story made you think?  What questions you have after listening to this story?

4

5

6 Ann Intern Med. 2002;136(12):888-895.

7  Recognize the importance of practicing evidence-based medicine  Develop a systematic approach to practicing evidence- based medicine  Calculate absolute risk reduction, relative risk, relative risk reduction, and number needed to treat

8

9 Ask Assess Apply Appraise Acquire

10 1. Ask: Convert the need for information into an answerable question. 2. Acquire: Track down the best evidence with which to answer that question. 3. Appraise: Critically appraise the evidence for its validity, impact, and applicability. 4. Apply: Integrate the evidence with our clinical expertise and our patient’s characteristics and values.

11

12 Background Question Foreground Question TYPE OF QUESTION CLINICAL EXPERIENCE

13

14  Background  Foreground

15  Cristina and Chris are sexually active. Chris is HIV negative. They are wondering what treatments are available to help Chris from contracting HIV while maintaining a sexual relationship. What do you tell them?

16

17  Cristina and Chris are sexually active. Chris is HIV negative. They are wondering what treatments are available to help Chris from contracting HIV while maintaining a sexual relationship.  P = HIV serodiscordant couples  I = Antiretroviral prophylaxis  C = Standard medical care, placebo  O = HIV seroconversion

18 1. Ask: Convert the need for information into an answerable question. 2. Acquire: Track down the best evidence with which to answer that question. 3. Appraise: Critically appraise the evidence for its validity, impact, and applicability. 4. Apply: Integrate the evidence with our clinical expertise and our patient’s characteristics and values.

19

20  Not all evidence is created equal  A heirarchy of evidence guides clinical decision making  Evidence alone is never enough  Competent physicians balance risks and benefits of management strategies in the context of patient values and preferences

21 Experimental Observational

22  P = HIV serodiscordant couples  I = Antiretroviral prophylaxis  C = Standard medical care, placebo  O = HIV seroconversion

23

24 1. Ask: Convert the need for information into an answerable question. 2. Acquire: Track down the best evidence with which to answer that question. 3. Appraise: Critically appraise the evidence for its validity, impact, and applicability. 4. Apply: Integrate the evidence with our clinical expertise and our patient’s characteristics and values.

25

26  Absolute Risk = Event Rate  The number of people experiencing an event as a proportion of the total number of people in a population  Key Words  Divide if you see  Relative  Ratio  Subtract if you see  Absolute  Difference  Reduction

27  200 pre-schoolers  100 pre-schoolers were randomized to drug X vs. 1o0 pre-schoolers to placebo for prevention of nose picking  10 kids receiving drug X still picked their noses  15 kids receiving placebo still picked their noses

28  Drug X event rate = 10%  Placebo event rate = 15%  There are only two things we can do to these numbers  Subtract, or  Divide

29  15% - 10% = 5%  What does this number represent?  Absolute Risk Reduction (ARR) or Risk Difference  Arithmetic difference between 2 event rates  We refer to the risk of the adverse outcome in the control group as the baseline risk Baseline Risk Experimental Risk

30  10% = 0.67 15%  What does this number represent?  Relative risk (RR)  Synonym = Risk Ratio  The proportion of the baseline risk that is still present when patients receive the experimental treatment Baseline Risk

31  “What proportion of the baseline risk has been reduced by the experimental treatment?”  RRR = 1 – RR = 1 – 0.67 = 0.33 = 33% OR  RRR = ARR/baseline risk = 5%/15% = 0.33 = 33%

32 50 25 10 5 2 1 ARR: RRR: 25% 50% 5%1% Control Exper.

33  NNT = 1/ARRWhy?  If ARR = 5%...  Treating 100 people reduces outcome in 5; How many do I need to treat to help 1?  Answer = 20 100 ? 5 1

34

35

36 Outcome Yes Outcome No TDF-FTC Placebo

37 Outcome Yes Outcome No TDF-FTC13/1576 Placebo

38 Outcome Yes Outcome No TDF-FTC13/15761563/1576 Placebo

39 Outcome Yes Outcome No TDF-FTC13/15761563/1576 Placebo52/1578

40 Outcome Yes Outcome No TDF-FTC13/15761563/1576 Placebo52/15781526/1578

41 Outcome Yes Outcome No TDF-FTC13/15761563/1576 Placebo52/15781526/1578 ARR = 52/1578 – 13/1576 = 0.025

42 Outcome Yes Outcome No TDF-FTC13/15761563/1576 Placebo52/15781526/1578 RRR = 1 – 0.25 = 0.75

43 Outcome Yes Outcome No TDF-FTC13/15761563/1576 Placebo52/15781526/1578 NNT = 1/ARR = 1/0.025 = 40

44 1. Ask: Convert the need for information into an answerable question. 2. Acquire: Track down the best evidence with which to answer that question. 3. Appraise: Critically appraise the evidence for its validity, impact, and applicability. 4. Apply: Integrate the evidence with our clinical expertise and our patient’s characteristics and values.

45

46 Matthew Tuck, MD Matthew.Tuck@va.gov 202-745-8000 x53994


Download ppt "November 5, 2014 Matthew Tuck, MD Hospitalist, Veterans Affairs Medical Center Assistant Professor of Medicine, George Washington University."

Similar presentations


Ads by Google